Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novo Nordisk A/S ADR
(NY:
NVO
)
128.31
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Apr 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
11,303
Open
128.31
Bid (Size)
125.42 (3)
Ask (Size)
125.50 (2)
Prev. Close
128.31
Today's Range
128.31 - 128.31
52wk Range
75.56 - 138.28
Shares Outstanding
N/A
Dividend Yield
1.38%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
3 of Europe’s ‘Magnificent 18’ Stocks That You Can Buy in the U.S.
April 30, 2024
The Magnificent Seven is so yesterday. The new trend is to invest in some of the top European stocks, dubbed the Magnificent 18.
Via
InvestorPlace
Eli Lilly Stock Jumps On Strong Earnings, Guidance As Zepbound Sales Easily Beat
April 30, 2024
Overall revenue fell short in Q1. Lilly stock is set to cross a key level.
Via
Investor's Business Daily
Performance
YTD
+25.66%
+25.66%
1 Month
+0.60%
+0.60%
3 Month
+17.69%
+17.69%
6 Month
+32.87%
+32.87%
1 Year
+53.28%
+53.28%
More News
Read More
Analyzing NYSE:NVO's Dividend Potential.
April 30, 2024
Via
Chartmill
Decoding Novo Nordisk's Options Activity: What's the Big Picture?
April 29, 2024
Via
Benzinga
Billionaire Investor Jim Simons Just Bought These 3 "Magnificent Seven" Stocks
April 29, 2024
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Is Viking Therapeutics Incredibly Undervalued?
April 28, 2024
Via
The Motley Fool
Here's How Much You Would Have Made Owning Novo Nordisk Stock In The Last 10 Years
April 26, 2024
Via
Benzinga
Is NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO) a Strong Candidate for Quality Investing?
April 25, 2024
Via
Chartmill
Why Novo Nordisk Topped the Market Today
April 22, 2024
Via
The Motley Fool
Forget Nvidia, These Unstoppable Stocks Are Better Buys
April 27, 2024
Via
The Motley Fool
1 Unstoppable Pharmaceutical Stock Investors Shouldn't Sleep On
April 27, 2024
Via
The Motley Fool
MarketBeat Week in Review – 4/22 - 4/26
April 27, 2024
Via
MarketBeat
Topics
Economy
Exposures
Economy
Interest Rates
What Are Pricing Strategies for Ozempic And Wegovy With Potential Medicare Coverage Expansion? Senate Committee Questions Novo Nordisk
April 24, 2024
Via
Benzinga
3 Biotech Stocks With Skyrocketing Potential: April 2024
April 24, 2024
Via
InvestorPlace
Meet Eli Lilly's Secret Weapon in the Billion-Dollar Weight-Loss Drug Market
April 24, 2024
Via
The Motley Fool
3 Speculative Weight Loss Drug Stocks to Bet On for Big Gains
April 24, 2024
Via
InvestorPlace
Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon.
April 24, 2024
Via
The Motley Fool
Better Buy: Pfizer vs. Viking Therapeutics
April 23, 2024
Via
The Motley Fool
3 Stocks With the Potential to Surpass Analyst Expectations for 2024
April 23, 2024
Via
InvestorPlace
Changing Frugal Eating Habits - How Novo Nordisk/Eli Lilly's Weight Loss Drugs Reshaping Food Spending
April 22, 2024
Via
Benzinga
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
April 22, 2024
Via
MarketBeat
2 Everlasting Big Pharma Stocks to Buy Today and Hold Forever
April 20, 2024
Via
The Motley Fool
MarketBeat Week in Review – 4/15 - 4/19
April 20, 2024
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
3 Relatively Safe Growth Stocks You Can Buy and Hold
April 20, 2024
Via
The Motley Fool
3 Biotech Stocks Set to Double by 2028
April 20, 2024
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.